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Title: Ultrasound Nakagami Imaging for Noninvasive Evaluation of Vaginal Fibrosis following Radiotherapy for Gynecologic Malignancies
Radiation therapy (RT) is an important treatment modality for most gynecologic (GYN) malignancies. However, radiotherapy can cause severe chronic vaginal toxicity months and even years after treatment. Vaginal fibrosis has been reported in 68% to 80% of women who have received pelvic and vaginal RT [1] . Vaginal toxicity leads to pain, sexual dysfunction, and poor quality of life. The purpose of this study is to develop a quantitative ultrasound technology to evaluate radiation-induced vaginal changes.
We have developed an ultrasound technology, combing ultrasound imaging and Nakagami parameter [2] [3] [4] , to assess post-RT vaginal toxicity in vivo. We enrolled 10 patients with endometrial cancer in this pilot study. Four patients who received surgery alone served as the control group. Six patients received surgery plus radiotherapy and the followup time ranged from 12 to 38 months after radiotherapy. Each participant underwent transvaginal ultrasound study with a 7.5 MHz biplane probe. Transverse images of the anterior vaginal wall were acquired in a step-wise progression from the apex (vaginal cuff) to the introitus (vagina opening). Nakagami parameters were calculated from the envelop signals generated from radio-frequency signals (see Figure 1) .
Vaginal toxicity appears to be associated with a thickened vaginal wall and increased Nakagami parameter. Figure 2 shows B-mode images and Nakagami images for a post-RT and non-irradiated patients. As shown in Fig. 3 , significant differences of the vaginal wall thickness and Nakagami parameter between post-RT and untreated patients have been observed. The vaginal wall of these patients appeared thicker than historical reports of non-irradiated women and enhanced Nakagami PDF was present; both findings suggestive of vaginal fibrosis. This study suggests that vaginal thickness and Nakagami parameter may be parameters that can assess radiation-induced vaginal injury. Our pilot study demonstrated the feasibility of using non-invasive ultrasound to evaluate radiationrelated vaginal fibrosis.
Conclusions:
Quantitative ultrasound provides a noninvasive, objective means of assessing radiation-induced vaginal changes. This imaging method may be useful as we try to address vaginal toxicities and sexual dysfunction after radiotherapy for female pelvic malignancies.
Significance: Despite significant incidence and severity of vaginal toxicity, sexual morbidity, and impact on Quality of life (QoL), little research has been conducted in pathophysiologic and molecular changes related to pelvic radiotherapy (RT) in women treated for pelvic cancers, in large part due to lack of methods to assess changes, such as fibrosis.
Innovation: This is the first translational study of using advanced ultrasound technology to study vaginal fibrosis in women who have received radiotherapy for GYN malignancies. 
